Company: ACBM
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001640334-25-001347
Chunk: 39

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-08-05
Form: 10-Q
Item: Item 8
Chunk 39
---
4 

For the three months ended June 30, 2025, we had no revenue or cost of revenue.  Our operating expenses were $13,614, which are primarily related to expenses and professional fees relating to our status as a public company. We also incurred interest expense to a minority stockholder of $1,948. As a result, we had a net loss of $15,562 or $(0.00) per share (basic and diluted).

 12Table of Contents

For the three months ended June 30, 2024, we had no revenue or cost of revenue.  Our operating expenses were $9,086 which are primarily relating to expenses and professional fees relating to our status as a public company. We also incurred interest expense to a minority stockholder of $1,057. As a result, we had a net loss of $10,143 or $(0.00) per share (basic and diluted).

For the six months ended June 30, 2025, we had no revenue or cost of revenue.  Our operating expenses were $22,548, which are primarily related to expenses and professional fees relating to our status as a public company. We also incurred interest expense to a minority stockholder of $3,315. As a result, we had a net loss of $25,863 or $(0.00) per share (basic and diluted).

For the six months ended June 30, 2024, we had no revenue or cost of revenue.  Our operating expenses were $19,384, which are primarily relating to expenses and professional fees relating to our status as a public company. We also incurred interest expense to a minority stockholder of $2,011. As a result, we had a net loss of $21,395 or $(0.00) per share (basic and diluted).

Liquidity and Capital Resources

The following table summarizes our changes in working capital from December 31, 2024 to June 30, 2025:

  June 30,2025  December 31,2024  Change  % Change Current assets $39,626  $5,076  $34,550   680.7%Current liabilities $370,797  $326,946  $43,851   13.4%Working capital (deficiency)  $(331,171 ) $(321,870 ) $9,301